C
디알텍
214680KOSDAQ의료용 기기 제조업47.8 / 100
Reference Date: 2026-06-10
Financial Score10.5 / 40
News Sentiment21.3 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Plunged 30.0% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
DRTECH is a global leader in digital diagnostic imaging solutions, offering end-to-end systems from X-ray equipment to detectors and components, leveraging over 20 years of expertise. Key products include mammography detectors, surgical X-ray systems, and veterinary/industrial detectors, with overseas sales accounting for approximately 80% of total revenue.
Number of Employees
381people
Average Salary
52.2M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 21.514.0Point
PBR
1.36Industry Average 1.384.0Point
In line with industry avg
ROE
-32.13Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
74.64Industry Average 11.650.0Point
6.4x industry avg (risky)
Trend 2023~20252.5 / 10 points
Revenue Growth Rate
2.5 / 3
Avg ▲12.4% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼4024.1% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -19.8% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85
- Positive디알텍, 외형성장에 수익성 개선 본격화…"글로벌 경쟁력 입증"
디알텍의 매출이 1000억원을 돌파하며 외형 성장을 이어가고 있어 글로벌 경쟁력이 입증되었다.
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 1,255Won52-week high 2,27552-week low 1,255
1-month return0.0Point
1m -30.01% (strong drop)
Volume trend5.0Point
Volume flat
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-02
- Neutral분기보고서 (2026.03)2026-05-15